(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -22.66%5.35B | -25.29%2.39B | -3.45%13.35B | -2.08%10.03B | 8.20%6.92B | 7.16%3.2B | 45.03%13.83B | 50.88%10.24B | 46.87%6.39B | 55.95%2.98B |
Operating income | -22.66%5.35B | -25.29%2.39B | -3.45%13.35B | -2.08%10.03B | 8.20%6.92B | 7.16%3.2B | 45.03%13.83B | 50.88%10.24B | 46.87%6.39B | 55.95%2.98B |
Operating expenses | 24.55%-3.86B | 26.65%-1.75B | 4.78%-10.08B | 5.61%-7.42B | -3.13%-5.11B | -0.41%-2.38B | -38.14%-10.59B | -44.78%-7.86B | -48.36%-4.96B | -55.00%-2.37B |
Gross profit | -17.31%1.49B | -21.33%639.64M | 0.89%3.27B | 9.59%2.61B | 25.69%1.8B | 33.45%813.07M | 73.26%3.24B | 75.31%2.38B | 41.96%1.44B | 59.77%609.28M |
Selling expenses | 4.19%-219.84M | 1.63%-109.12M | -21.45%-502.29M | -27.89%-347.72M | -33.24%-229.45M | -30.89%-110.94M | -53.27%-413.58M | -40.24%-271.89M | 30.58%-172.21M | -70.69%-84.75M |
Administrative expenses | -3.35%-495.5M | -6.20%-241.2M | -34.58%-1.05B | -38.06%-738.38M | -55.99%-479.44M | -50.51%-227.11M | -25.40%-778.8M | -26.74%-534.81M | -7.82%-307.35M | -22.50%-150.89M |
Research and development expenses | 5.43%-347.61M | 13.84%-156.13M | 1.13%-774.99M | -2.62%-558.71M | -14.87%-367.56M | -30.10%-181.21M | -65.67%-783.89M | -70.08%-544.43M | -59.37%-319.98M | -70.64%-139.29M |
Profit from asset sales | -460.15%-6.29M | 303.68%1.98M | 7.15%-2.22M | 267.60%2.42M | 15.39%-1.12M | 174.03%490.01K | -597.10%-2.4M | -87.79%-1.44M | -152.30%-1.33M | -2,051.53%-661.87K |
Revaluation surplus | -43.94%2.71M | -54.46%1.2M | 13.70%10.77M | 849.56%5.9M | 377.09%4.83M | 231.58%2.64M | -97.21%9.47M | -100.25%-787.06K | -100.54%-1.74M | 160.43%795.3K |
-Changes in the fair value of other assets | -43.94%2.71M | -54.46%1.2M | 13.70%10.77M | 849.56%5.9M | 377.09%4.83M | 231.58%2.64M | -97.21%9.47M | -100.25%-787.06K | -100.54%-1.74M | 160.43%795.3K |
Impairment and provision | 28.12%-106.73M | 16.68%-30.31M | -16.67%-237.85M | -50.53%-154.85M | -101.27%-148.49M | 5.48%-36.38M | -30.17%-203.87M | 20.97%-102.87M | 30.35%-73.78M | 14.60%-38.49M |
-Other impairment is provision | 28.12%-106.73M | 16.68%-30.31M | -16.67%-237.85M | -50.53%-154.85M | -101.27%-148.49M | 5.48%-36.38M | -30.17%-203.87M | 20.97%-102.87M | 30.35%-73.78M | 14.60%-38.49M |
Special items of operating profit | -112.83%-23.26M | -115.24%-5.25M | 168.47%723.01M | 128.88%257.69M | 160.03%181.24M | -34.01%34.48M | 46.20%269.31M | 20.93%112.59M | 12.68%69.7M | 43.62%52.26M |
Operating profit | -64.44%251.37M | -71.66%79.1M | 7.42%1.35B | 1.91%992.79M | 19.03%706.87M | 19.34%279.07M | 48.98%1.25B | 43.66%974.21M | 10.77%593.85M | 107.35%233.85M |
Financing cost | -305.04%-88.17M | -13.81%-37.79M | -53.63%-127.33M | -67.63%-101.18M | 39.58%-21.77M | -150.14%-33.21M | 32.50%-82.88M | 32.98%-60.36M | 23.42%-36.03M | 38.54%-13.28M |
Special items of earning before tax | 4,616.80%183.9M | 251.75%3.73M | 87.38%-2.31M | 468.15%820.4K | -419.18%-4.07M | -492.24%-2.46M | -161.60%-18.28M | -100.77%-222.84K | -95.36%1.28M | 149.16%627.26K |
Earning before tax | -49.03%347.11M | -81.50%45.04M | 5.60%1.22B | -2.32%892.43M | 21.81%681.03M | 10.04%243.4M | 54.01%1.15B | 48.11%913.63M | 8.24%559.09M | 146.06%221.2M |
Tax | 64.96%-19.16M | 49.58%-11.74M | -525.93%-39.49M | -34.85%-67.16M | -31.13%-54.67M | -115.28%-23.28M | 133.93%9.27M | -22.89%-49.8M | -35.53%-41.7M | -285.14%-10.82M |
After-tax profit from continuing operations | -47.64%327.95M | -84.87%33.3M | 1.35%1.18B | -4.46%825.27M | 21.06%626.36M | 4.63%220.12M | 61.13%1.16B | 49.88%863.83M | 6.51%517.4M | 141.57%210.38M |
Earning after tax | -47.64%327.95M | -84.87%33.3M | 1.35%1.18B | -4.46%825.27M | 21.06%626.36M | 4.63%220.12M | 61.13%1.16B | 49.88%863.83M | 6.51%517.4M | 141.57%210.38M |
Minority profit | -357.40%-49.8M | -17.70%-24.62M | -1,993.09%-120.5M | -376.99%-55.32M | 341.96%19.35M | -407.44%-20.92M | -147.31%-5.76M | -195.21%-11.6M | -221.20%-8M | 159.13%6.8M |
Profit attributable to shareholders | -37.77%377.75M | -75.97%57.92M | 11.18%1.3B | 0.59%880.59M | 15.54%607.01M | 18.40%241.04M | 64.71%1.17B | 55.17%875.42M | 9.65%525.39M | 141.03%203.58M |
Basic earnings per share | -37.50%0.5 | -75.00%0.08 | 11.04%1.71 | 0.00%1.16 | 15.94%0.8 | 18.52%0.32 | 63.83%1.54 | 54.67%1.16 | 9.52%0.69 | 145.45%0.27 |
Diluted earnings per share | -37.50%0.5 | -75.00%0.08 | 11.04%1.71 | 0.00%1.16 | 15.94%0.8 | 18.52%0.32 | 63.83%1.54 | 56.76%1.16 | 9.52%0.69 | 145.45%0.27 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data